This company has a significant chance of early FDA acceptance any day now.

Company structure is good, FDA claearance much closer compared to last years.

$NOVN I’m not over-stating or exaggerating for affect—-but it feels so damn good after all the studies and all these years that this drug is FINALLY in the hands of the FDA!

when they announce the FDA submission it’ll climb again.

$HOTH amazing how this is still red after fda approval.

$HOTH simply keeping buying and holding Many to buy back here They can all see $33 buy rating and FDA release

$HOTH This is massive opportunity now with FDA NDA approval for cancer and pending BIOLEXA approval, as well as HOTH now fully funded until 2024.

$HOTH cancer FDA NDA approved now so $35-45 is fair value given the market rates Low float and low mkt cap Fully funded into 2024 is huge bonus here Good to be buying below $15 for now

$HOTH This is massive opportunity now with FDA NDA approval for cancer and pending BIOLEXA approval, as well as HOTH now fully funded until 2024.

$HOTH Another FDA play that we absolutely crushed for 75%+ gains! BOOM!

Saw the manipulation and added the dip More next week Nice and easy now Almost Zero fear or risk now Fully funded now and plenty on fda to come too

$TGTX $KALA $HOTH $NUWE TGTX on fire 🔥 and solid from fundamentals perspective after yesterday FDA approval of Multiple Sclerosis Billion dollar drug revenue potential.

$HOTH very low float here Good to see funding out of the way following fda news

Very similar news to $KALA… FDA is HOT!

Good FDA news -- stock is up!

we can hear about FDAs decision anyday starting Thursday..exciting times ahead

but a positive for the FDA as Dr. Stein looks at the label.

*******” another BIG reason why the FDA should approve it!!! !

Home run with FDA, path forward soon.

And some are saying oh its just an opinion, this is actually fantastic news for us and will open the door to other countries for approval and HOPEFULLY the US fda will approve it.

$AKBA We should be very happy at current recovery, Im holding the rest of my position right into partner, FDA the lot Yesterdays news was amazing

It is clean for the FDA.

This bodes very well for fda FDRR approval.

$AKBA FDA, please listen and read: “The benefit of Vafseo is its ability to correct haemoglobin levels in dialysis-dependent patients, with effects comparable to those seen with erythropoiesis-stimulating agents.